Arctic Vision
Manufacturing · China · 51-200 Employees
View Company Info for Free
Overview
Headquarters
17f tower 1 Century Link Ste 1732 1198, ...Phone Number
+358 400394163Website
www.arcticvision.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Arctic Vision
Arctic Vision is a China-based ophthalmic biotech company dedicated to developing innovative therapies for ophthalmic conditions, with a product portfolio that spans from pre-clinical to commercial stages. The company aims to address unmet clinical needs in China, Asia, and globally, benefiting a wide range of ophthalmic patients. Led by a team of experienced professionals in the ophthalmic industry, Arctic Vision is supported by top-tier life sciences investors. Their focus includes breakthrough therapies for conditions such as glaucoma and uveitic macular edema.Explore more
Arctic Vision Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Arctic Vision your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Arctic Vision
Arctic Vision, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Arctic Vision launches new products
Check out if Arctic Vision is spiking on competitors!
Click to see if Arctic Vision had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Arctic Vision has new funding data
Check if Arctic Vision has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Arctic Vision recently announced quarterly report
Recommended Actions
Find VP level buyers at Arctic Vision
Find 3 more new buyers
Company Profile Activity
Activity Insights
Arctic Vision is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Arctic Vision is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Arctic Vision.
Arctic Vision financials insights
Gather financial insights about Arctic Vision, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$32M
2021
Series B
$100M
Arctic Vision Tech Stack
A closer look at the technologies used by Arctic Vision
Arctic Vision News & Media
Arctic Vision Announces Deal to Integrate MDCO Technology’s Ophthalmic Device Business to Form a Global Drug–Device Innovation Platform
SHANGHAI, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Headquartered in Shanghai, Arctic Vision (Cayman) Limited (“Arctic Vision”), a global ophthalmic company, announced that it has entered into an agreement to acquire the innovative ophthalmic device business of MDCO Technology, a Hangzhou-based ophthalmic medical-device company.Clearside Biomedical’s Asia-Pacific Partner, Arctic Vision, Announced Acceptance of its New Drug Application for ARCATUS® for Regulatory Review in China for the Treatment of Uveitic Macular Edema
ALPHARETTA, Ga., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), reported that Arctic Vision’s New Drug Application (NDA) for ARCATUS® for the treatment of uveitic macular edema (UME) has been formally accepted for review by the Center for Drug Evaluation of China National Medical Products Administration.Clearside Biomedical Announces its Asia-Pacific Partner, Arctic Vision, Received Approval of Suprachoroidal Treatment for Uveitic Macular Edema in Australia and Singapore
- ARCATUS®, Branded as XIPERE® in the U.S., is the First Globally Approved Suprachoroidal Therapy -Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular Edema
- Partnership Creates New Opportunities to Address Unmet Needs Related to Posterior Segment Eye Diseases in China -
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Arctic Vision
Sign Up For FreeTo access detailed company insights
Arctic Vision is a China-based ophthalmic biotech company dedicated to developing innovative therapies for ophthalmic conditions, with a product portfolio that spans from pre-clinical to commercial stages. The company aims to address unmet clinical needs in China, Asia, and globally, benefiting a wide range of ophthalmic patients. Led by a team of... Read More
